MedTrace Logo

A Study of Levornidazole Disodium Phosphate for Injection vs. Ornidazole in Treatment of Postoperative Intra-Abdominal Infections Caused by Anaerobic Bacteria

NCT06828874 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 696

Last updated 2025-02-18

No results posted yet for this study

Summary

Anaerobic infections are very common in clinical practice. Poor control of anaerobic infections in patients undergoing abdominal surgery may lead to the occurrence of complications. The aim of this study is to explore the efficacy and safety of Levornidazole Phosphate Disodium for Injection in the treatment of patients with postoperative intra-abdominal infections caused by anaerobic bacteria.

Conditions

  • Intraabdominal Infections

Interventions

DRUG

Levornidazole Disodium Phosphate for Injection

1g，once daily, intravenously guttae for 4 to 7 days

DRUG

Ornidazole and Sodium Chloride Injection

0.5g at a time , 2 times per day, intravenously guttae for 4 to 7 days

Sponsors & Collaborators

  • Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co. Ltd

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-10
Primary Completion
2024-09-23
Completion
2024-10-14

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06828874 on ClinicalTrials.gov